富陽(00352.HK)預計年度淨虧損大幅減少或轉虧為盈不超50萬元
格隆匯 3 月 8日丨富陽(00352.HK)公佈,相較前一年度錄得的虧損人民幣1670萬元,預期集團於截至2020年12月31日止年度錄得淨虧損大幅減少或轉虧為盈不超過人民幣50萬元。
該大幅虧損減少或轉虧為盈主要是由於(i)在該年度內集團在中國之綜合房地產諮詢及代理服務的營業額及毛利率因該年度在中國的住宅物業需求增加而有所增加;(ii)集團因實施了嚴謹的成本控制政策及該年度的出差次數大幅減少而導致一般及行政開支大幅減少;以及(iii)公司日期為2020年11月25日及2020年12月1日的公吿所提及法院對集團前客户作出的正面裁定的一次性盈利所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.